{"ticker": {"uuid": "fe268598-a208-4901-9007-b44308287406", "symbol": "INIFY", "name": "INIFY Laboratories AB", "exchange": "OSL", "country": "NO", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "CapEx per share of INIFY Laboratories AB \u2013 OSL:INIFY", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQclhib1JLS0tSdU5QU2k5ZUV4RVFqeWs4WG93emYwYzBaU0h4OENMSVZDd0dmNnJTRVRxZzJmSmEzbDZMbnlzeGRkVjdRU1MwYzBUZHBiM2VmTXlDeTg5VXl4bjF0QWNXRnNJUnVac29QV2pSb0NoSi1fZ0RvaFB4V29RS25LQ3lfWjFtUnNuM0Q3ZWcyd1dXMDhRQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T02:08:51+00:00", "published_display": "16 Jun 2026 02:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inify Laboratories AB: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AJBVV95cUxObmZ2YTFnUDgydlU3bmN0YmNMaVFLdjNIRXp1bFhCNXNFeXRuaElteGNJT0xKUWxLLTdMMkNDWnVSU0lIeUhsdEJ4MXRQZGIzZE15TlJVNVAzdHNmOW50YjIxM3ZTUExhWlp5NlRzZWhqb195SnVZazE1cXgzVHlva0ZGQjM0WWNpS29DVTZCeEFqTFRGTGVKTE94Y3FRN2Z1QU1LT2ZqNDNtcDdTVlpvdHlQcnVTREJEdzE4Wmd4VFZnVGh4OHZUTnl5SWV2dUZaTjAzSng3aHpnT3Mta08xM3pHQ2poUkZCZzJrNEg5SDNPVjlWUXJFcmVWY1V1dmRtQlN1WU5yLWI3Yi1BcUJwb1RVTlI0UHhfWDNPMlpZSXlvdVduVkVnTVg3QVJEMTBISGN4QVFNYTBIc2plOUV2dDlkaVk4QWNDQklGMWRPUDRpSmJSeDc1dA?oc=5", "source_name": "Finansavisen", "published_at": "2026-06-08T13:13:37+00:00", "published_display": "08 Jun 2026 13:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inify Laboratories AB: Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgJBVV95cUxQQUZxMWtkT25mN1R3X29WQ1B0Zk1YYzNVYlREblNvMHF3X0hwVlVVQ3U1UDc4ZE0tZjhHYkRZLUk3cVJ1OFN2ZFBkMFctWEdhUndZS296STAzNTFhMnpRZW50UVVxMUdxX2hFTjE0dUNEMzl0b2w2am5WYktPNnViY0xCdlRBT1EzeEhmZENyQnZDRHdjLWl2Vks3N3dOT1p4YXdPNkxUMDhoTWN0aVZiTE1qYlFIR1R1aHZWVWF0SGFqN3NyRmJDbGp5dHB4cDM5QU1CdFZ0UDdFWFVGeHdVckdNZ2oyQ2RnNzJsN29HY1BYdWNrM2Y2cWVHTHdpbnFSSm5HMzE5X3oyQXlPaHJib091SVJYalpodkVIZ1hZdHZkbXJhcWZtVUxZbDh5UQ?oc=5", "source_name": "Finansavisen", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CapEx per share of INIFY Laboratories AB \u2013 OSL:INIFY", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQclhib1JLS0tSdU5QU2k5ZUV4RVFqeWs4WG93emYwYzBaU0h4OENMSVZDd0dmNnJTRVRxZzJmSmEzbDZMbnlzeGRkVjdRU1MwYzBUZHBiM2VmTXlDeTg5VXl4bjF0QWNXRnNJUnVac29QV2pSb0NoSi1fZ0RvaFB4V29RS25LQ3lfWjFtUnNuM0Q3ZWcyd1dXMDhRQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T02:08:51+00:00", "published_display": "16 Jun 2026 02:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inify Laboratories AB: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AJBVV95cUxObmZ2YTFnUDgydlU3bmN0YmNMaVFLdjNIRXp1bFhCNXNFeXRuaElteGNJT0xKUWxLLTdMMkNDWnVSU0lIeUhsdEJ4MXRQZGIzZE15TlJVNVAzdHNmOW50YjIxM3ZTUExhWlp5NlRzZWhqb195SnVZazE1cXgzVHlva0ZGQjM0WWNpS29DVTZCeEFqTFRGTGVKTE94Y3FRN2Z1QU1LT2ZqNDNtcDdTVlpvdHlQcnVTREJEdzE4Wmd4VFZnVGh4OHZUTnl5SWV2dUZaTjAzSng3aHpnT3Mta08xM3pHQ2poUkZCZzJrNEg5SDNPVjlWUXJFcmVWY1V1dmRtQlN1WU5yLWI3Yi1BcUJwb1RVTlI0UHhfWDNPMlpZSXlvdVduVkVnTVg3QVJEMTBISGN4QVFNYTBIc2plOUV2dDlkaVk4QWNDQklGMWRPUDRpSmJSeDc1dA?oc=5", "source_name": "Finansavisen", "published_at": "2026-06-08T13:13:37+00:00", "published_display": "08 Jun 2026 13:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inify Laboratories AB: Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgJBVV95cUxQQUZxMWtkT25mN1R3X29WQ1B0Zk1YYzNVYlREblNvMHF3X0hwVlVVQ3U1UDc4ZE0tZjhHYkRZLUk3cVJ1OFN2ZFBkMFctWEdhUndZS296STAzNTFhMnpRZW50UVVxMUdxX2hFTjE0dUNEMzl0b2w2am5WYktPNnViY0xCdlRBT1EzeEhmZENyQnZDRHdjLWl2Vks3N3dOT1p4YXdPNkxUMDhoTWN0aVZiTE1qYlFIR1R1aHZWVWF0SGFqN3NyRmJDbGp5dHB4cDM5QU1CdFZ0UDdFWFVGeHdVckdNZ2oyQ2RnNzJsN29HY1BYdWNrM2Y2cWVHTHdpbnFSSm5HMzE5X3oyQXlPaHJib091SVJYalpodkVIZ1hZdHZkbXJhcWZtVUxZbDh5UQ?oc=5", "source_name": "Finansavisen", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 55, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 8.0, "latest_week": "2026-06-19", "one_week_move": 0.0, "four_week_move": 121.0, "twelve_week_move": 70.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.200878, "market_dynamics_buy_signal": false, "relative_strength": 46.869204, "fair_value_gap": 4.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 36.435, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +121.0% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Finansavisen", "count": 2}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +121.0% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CapEx per share of INIFY Laboratories AB \u2013 OSL:INIFY"}], "updated_at": "2026-06-22T18:04:54.552547+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}